These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29377277)

  • 1. Business of dialysis and the role of the medical director.
    Scheel PJ
    Semin Dial; 2018 Mar; 31(2):177-182. PubMed ID: 29377277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The medical director and quality requirements in the dialysis facility.
    Schiller B
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):493-9. PubMed ID: 25376762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the medical director: changing with the times.
    Maddux FW; Maddux DW; Hakim RM
    Semin Dial; 2008; 21(1):54-7. PubMed ID: 18251959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment center characteristics associated with better outcomes: a role for the medical director?
    Spiegel BM
    Semin Dial; 2012 May; 25(3):296-8. PubMed ID: 22607212
    [No Abstract]   [Full Text] [Related]  

  • 5. Can better understanding and use of treatment center performance feedback improve hemodialysis care? A role for the medical director.
    DeOreo PB; Wilson R; Wish JB
    Semin Dial; 2012 May; 25(3):290-3. PubMed ID: 22494265
    [No Abstract]   [Full Text] [Related]  

  • 6. What is expected of a medical director in the Centers for Medicare and Medicaid Services Conditions of Coverage?
    Wish JB
    Blood Purif; 2011; 31(1-3):61-5. PubMed ID: 21228568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dialysis medical director's role in quality and safety.
    Kliger AS
    Semin Dial; 2007; 20(3):261-4. PubMed ID: 17555492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The medical directorship of renal dialysis facilities under the new Medicare conditions for coverage: challenges and opportunities.
    DeOreo PB
    Blood Purif; 2009; 27(1):16-21. PubMed ID: 19169012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Director Responsibilities to the ESRD Network.
    DeOreo PB; Wish JB
    Clin J Am Soc Nephrol; 2015 Oct; 10(10):1852-8. PubMed ID: 25255911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How dialysis is paid for: what the dialysis medical director should know, and why.
    Deoreo PB
    Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare program; end-stage renal disease quality incentive program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Jan; 76(3):627-46. PubMed ID: 21261127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the role of the medical director in the dialysis unit.
    McMurray SD
    Nephrol News Issues; 2000 Jul; 14(8):37-9. PubMed ID: 12101519
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leading the Dialysis Unit: Role of the Medical Director.
    Saha S; Wish JB
    Adv Chronic Kidney Dis; 2018 Nov; 25(6):499-504. PubMed ID: 30527549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring, managing, and improving the quality of end-stage renal disease care.
    Levinsky NG; Mesler DE
    Am J Kidney Dis; 1994 Aug; 24(2):235-46. PubMed ID: 8048431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first DRG: lessons from the end stage renal disease program for the prospective payment system.
    Maxwell JH; Sapolsky HM
    Inquiry; 1987; 24(1):57-67. PubMed ID: 2951335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding financial risk models: Implicationsfor nephrology practices and dialysis centers.
    Cellini GL
    Nephrol News Issues; 2016 Mar; 30(3):26-8, 30-3. PubMed ID: 27169216
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare Program; End-Stage Renal Disease Prospective Payment System, and Quality Incentive Program. Final Rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2015 Nov; 80(215):68967-9077. PubMed ID: 26552112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare program; end-stage renal disease (ESRD) payment exception requests and organ procurement costs--HCFA. Final rule.
    Fed Regist; 1997 Aug; 62(158):43657-74. PubMed ID: 10169837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of diagnosis-related groups on the cost of hospitalization for end-stage renal disease patients at Rhode Island Hospital from 1987 to 1990.
    Chazan JA; London MR; Pono L
    Am J Kidney Dis; 1992 Jun; 19(6):523-5. PubMed ID: 1595699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.